Nursing Approach to Fecal Microbiota Transplantation Applied to Child Patients

Yıl 2021, Cilt: 2 Sayı: 3, 91 - 95, 30.12.2021

Tuğba Dede Müjde Çalıkuşu İncekar

https://doi.org/10.51261/yiu.2021.00039

Öz

Fecal Microbiota Transplantation FMT is the process of taking stool from a healthy donor and placing it in the gastrointestinal tract of the sick individual. Today, it has been seen that FMT is mostly used for the treatment of clostridium difficile infection. Depending on the child’s condition, physician preferences, and/or protocol requirements, the route of administration in the FMT procedure can be oral capsule, upper or lower gastrointestinal route. Detailed information about FMT, including all aspects of the process, needs to be provided in writing to children, families and donors. Pediatric nurses should plan the individualized care process with a holistic approach based on child-centered care, family-centered care, atraumatic care models in the management of the FMT process. It is the nurse’s responsibility to increase the child’s comfort, protect his privacy, and prevent complications that may arise in the child. Because the FMT procedure is a specific application, nurses need to have detailed information about a qualified nursing process. In this review, the topics of microbiota, FMT and the nursing process before, during and after the procedure are discussed.

Anahtar Kelimeler

Child, fecal microbiota transplantation, nursing, pediatrics

Çocuk Hastalara Uygulanan Fekal Mikrobiyota Transplantasyonuna Yönelik Hemşirelik Yaklaşımı

Öz

Fekal Mikrobiyota Transplantasyonu FMT , gaitanın sağlıklı vericiden alınıp hasta bireyin gastrointestinal kanalına konulması işlemidir. Günümüzde FMT’nin en fazla clostridium difficile enfeksiyonunun tedavisi için kullanıldığı görülmüştür. FMT işleminde uygulama yolu, çocuğun durumuna, doktor tercihlerine ve / veya protokol gerekliliğine bağlı olmakla birlikte kapsül olarak oral yoldan ya da üst veya alt gastrointestinal yoldan uygulanabilmektedir. Sürecin tüm yönlerini içeren FMT hakkında ayrıntılı bilgilerin yazılı olarak çocuklara, ailelere ve bağışçılara sunulması gerekmektedir. Pediatri hemşireleri FMT sürecinin yönetiminde çocuk merkezli bakım, aile merkezli bakım, atravmatik bakım modellerini baz alarak holistik yaklaşım ile bireyselleştirilmiş bakım sürecini planlamalıdır. Çocuğun konforunun artırılması, mahremiyetinin korunması ve çocukta ortaya çıkabilecek komplikasyonların önlenmesi hemşirenin sorumluluğundadır. FMT işleminin spesifik bir uygulama olması nedeniyle hemşirelerin, nitelikli bir hemşirelik süreci hakkında detaylı bilgiye sahibi olmaları gerekmektedir. Bu derlemede mikrobiyota, FMT ve işlem öncesi, sırası ve sonrası hemşirelik süreci konuları ele alınmıştır.

Anahtar Kelimeler

Çocuk, fekal mikrobiyota transplantasyonu, hemşirelik, pediatri

Kaynakça

• Demirci H, Uygun A. Fekal Transplantasyon Nasıl ve Kime Uygulanmalı? Güncel Gastroenteroloji 2014;18 4 :444-7.
• Gupta A, Khanna S. Fecal Microbiota Transplantation. JAMA 2017;4;318 1 :102. https://doi.org/10.1001/jama.2017.6466
• Bıkmaz Z, Çiçek M. Fekal Mikrobiyota Transplantasyonu ve Hemşirelik. Genel Sağlık Bilimleri Dergisi 2020;2 2 :91-108.
• Haque SZ, Haque M. The ecological community of commensal, symbiotic, and pathogenic gastrointestinal microorganisms–an appraisal. Clin Exp Gastroenterol 2017;10,91-103. https://doi.org/10.2147/CEG.S126243
• Guinane CM., Cotter PD. Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ. Therap Adv Gastroenterol 2013;6 4 : 295–308. https://doi. org/10.1177/1756283X13482996
• Koca O, Dönmez, N. İkinci beyin: Bağırsak. Atatürk Üniversitesi Veteriner Bilimleri Dergisi 2020;15 2 , 187-195.
• Costello EK, Stagaman K, Dethlefsen L, Bohannan BJ, Relman DA. The application of ecological theory toward an understanding of the human microbiome. Science 2012;336:1255-1262. https://doi.org/10.1126/ bilim.1224203
• Matamoros S, Gras-Leguen C, Le Vacon, F, Potel G, de La Cochetiere MF. Development of intestinal microbiota in infants and its impact on health. Trends Microbiol 2013;21:167-173. https://doi.org/10.1016/j. tim.2012.12.001
• Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, Fierer N, Knight R. Delivery mode shapes the acquisition and structure of the initial microbiota cross multiple body habitats in newborns. Proc Natl Acad Sci USA 2010;107:11971-11975. https://doi.org/10.1073/pnas.1002601107
• Olszak T, An D, Zeissig S, Vera MP, Richter J, Franke A, et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science 2012;336:489-93. https://doi.org/10.1126/bilim.1219328
• Wang HX, Wang YP. Gut Microbiota-brain Axis. Chin Med J Engl 2016;129, 2373-80. https://doi.org/10.4103/0366-6999.190667
• Sender R, Fuchs S, Milo R. Revised Estimates for the Number of Human and Bacteria Cells in the Body. PLoS Biol 2016;14:e1002533. https://doi. org/10.4103/0366-6999.190667
• Yoo BB, Mazmanian SK. The Enteric Network: Interactions between the Immune and Nervous Systems of the Gut. Immunity 2017;46,910-926. https:// doi.org/10.1016/j.immuni.2017.05.011
• Kernbauer E, Ding Y, Cadwell K. An enteric virus can replace the beneficial function of commensal bacteria. Nature 2014;516 7529 , 94-98. https://doi. org/10.1038/nature13960
• Abdollahi-Roodsaz S, Abramson SB, Scher JU. The metabolic role of the gut microbiota in health and rheumatic disease: mechanisms and interventions. Nat Rev Rheumatol 2016;12:446-55. doi: 10.1038/nrrheum.2016.68
• Tamburini S, Shen N, Wu HC, Clemente JC. Themicrobiome in early life: implicationsforhealthoutcomes.NatMed 2016;22:713-22. https://doi. org/10.1038/nm.4142
• Collado MC, Rautava S, Isolauri E, Salminen S. Gut microbiota: a source of noveltoolstoreducethe risk of humandisease? Pediatr Res 2015;77:182-88. https://doi.org/10.1038/pr.2014.173
• Gagliardi A, Totino V, Cacciotti F, Iebba V, Neroni B, Bonfiglio G, et al. Rebuilding the Gut Microbiota Ecosystem. International journal of environmental research and public health 2018;15 8 . https://doi.org/10.3390/ ijerph15081679
• Eiseman B, Silen W, Bascom GS, Kauvar AJ. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 1958,44 5 :854-9.
• Uygun A. Fekal Mikrobiyota Transplantasyonu. Journal of Biotechnology and Strategic Health Research 2017;1 Special issue :132-140.
• Rossen NG, MacDonald JK., de Vries EM, D’Haens GR, de Vos WM, Zoetendal EG., et al. Fecal microbiota transplantation as novel therapy in gastroenterology: a systematic review. World J Gastroenterol 2015;21 17 :5359-71. https://doi. org/10.3748/wjg.v21.i17.5359
• Sürücü Y, Akyüz E. Fekal mikrobiyota transplantasyonu ve hastalıklar üzerine etkileri. Sağlık Akademisyenleri Dergisi 2020;7 4 :296-303.
• Kunde S, Pham A, Bonczyk S, Crumb T, Duba M, Conrad H, et al. Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis. Journal of Pediatric Gastroenterology and Nutrition 2013;56:597–601. https://doi.org/10.1097/MPG.0b013e318292fa0d
• Aroniadis OC, Brandt LJ. An overview of fecal microbiota transplantation: Techniques, indications, and outcomes. Gastrointestinal Endoscopy 2013;78 2 :240-249. https://doi.org/10.1016/j.gie.2013.03.1329
• Kassam Z, Lee CH, Yuan Y, Hunt RH. Fecal microbiota transplantation for clostridium difficile ınfection: systematic review and meta-analysis. The American Journal of Gastroenterology 2013;108 4 :500-8. https://doi. org/10.1038/aj.2013.59
• Van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, et al. Duodenal infusion of donor feces for recurrent clostridium difficile. New England Journal of Medicine 2013;368 5 :407-15. https://doi.org/10.1056/ NEJMoa1205037
• Boyle ML, Ruth-Sahd LA, Zhou Z. Fecal microbiota transplant to treat recurrent clostridium difficile infections. Critical Care Nurse 2015;35 2 :51- 64. https://doi.org/10.4037/ccn2015356
• Kao D, Hotte N, Gillevet P, Madsen K. Fecal microbiota transplantation ınducing remission in crohn’s colitis and the associated changes in fecal microbial profile. Journal of Clinical Gastroenterology 2014;48 7 :625-628. https://doi.org/10.1097/MCG.0000000000000131
• Bafeta A, Yavchitz A, Riveros C, Batista R, Ravaud P. Methods and reporting studies assessing fecal microbiota transplantation: A systematic review. Annals of Internal Medicine 2017;167 1 :34-39. https://doi.org/10.7326/M16-2810
• Paramsothy S, Kamm MA, Kaakoush NO, Walsh AJ, van den Bogaerde J, Samuel D, et al. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. The Lancet 2017;389 10075 :1218-28. https://doi.org/10.1016/S0140-6736 17 30182-4
• Wang J-W, Kuo C-H, Kuo F-C, Wang Y-K, Hsu W-H, Yu F-J, et al. Fecal microbiota transplantation: Review and update. Journal of the Formosan Medical Association 2019;118 Supplement 1 :23-31. https://doi.org/10.1016/j. jfma.2018.08.011
• Hamilton MJ, Weingarden AR, Sadowsky MJ, Khoruts A. Standardized frozen preparation for recurrent Clostridium difficile infection. The American Journal of Gastroenterology 2012;107:761–767. https://doi.org/10.1038/ajg.2011.482.
• Sokol H, Galperine T, Kapel N, Bourlioux P, Seksik P, Barbut F, et al. Faecal microbiota transplantation in recurrent Clostridium difficile infection: Recommendations from the French Group of Faecal microbiota Transplantation. Dig Liver Dis 2016;48 3 :242-247. https://doi.org/10.1016/j.dld.2015.08.017
• Cammarota G, Ianiro G, Tilg H, Rajilić-Stojanović M, Kump P, Satokari R, et al. European consensus conference on faecal microbiota transplantation in clinical practice. Gut 2017;66 4 :569-80. https://doi.org/10.1136/gutjnl-2016-313017
• Bakken JS, Borody T, Brandt LJ, Brill JV, Demarco DC, Franzos MA. Treating Clostridium difficile Infection With Fecal Microbiota Transplantation. Clin Gastroenterol Hepatol 2011;9 12 :1044-1049. https://doi.org/10.1016/j. cgh.2011.08.014
• Cammarota G, Ianiro G, Bibbò S, Gasbarrini A. Gut microbiota modulation: probiotics, antibiotics or fecal microbiota transplantation? Intern Emerg Med 2014;9:365-373. https://doi.org/10.1007/s11739-014-1069-4
• Samuel BP, Crumb TL, Duba MM. What Nurses Need to Know About Fecal Microbiota Transplantation: Education, Assessment, and Care for Children and Young Adults. Journal of Pediatric Nursing 2014;29,354–361. https://doi. org/10.1016/j.pedn.2014.01.013
• Youngster I, Sauk J, Pindar C, Wilson RG, Kaplan JL, Smith MB, et al. Fecal Microbiota Transplant for Relapsing Clostridium difficile Infection Using a Frozen Inoculum From Unrelated Donors: A Randomized, Open-Label, Controlled Pilot Study. Clinical Infectious Diseases: An Offi cial Publication of the Infectious Diseases Society of America. 2014;58 11 :1515-1522. doi:10.1093/cid/ciu135.
• Lin T-C, Hung Y-P, Ko W-C, Ruan J-W. Fecal Microbiota Transplantation for Clostridium difficile Infection in Taiwan: Establishment and Implementation. J Microbiol Immunol Infect 2019;52 6 :841-50. https://doi.org/10.1016/j. jmii.2019.08.009
• Çavuşoğlu H. Pediatri Kliniklerinde Aile Merkezli Bakımda Yaşanan Sorunlar ve Yeni Yaklaşımlar. Türkiye Klinikleri Hemşirelik Bilimleri Dergisi 2018;10 4 :344-353. https://doi.org/10.5336/nurses.2018-61413
• Kaya S, Karayağız G, Manav G. Türkiye’de Pediatri Kliniklerinde Yapılan ve Aile Merkezli Bakım Anlayışını Kapsayan Çalışmaların Gözden Geçirilmesi. Balıkesir Sağlık Bilimleri Dergisi 2020;9 3 :205-214.
• Doğan P, Akcay N, Yılmaz HB. Pediatri Hemşireliğinde Önemli Bir Girişim: Atravmatik Bakım ve Yaklaşımları. İzmir Katip Çelebi Üniversitesi Sağlık Bilimleri Fakültesi Dergisi 2021;6 2 :131-135.
• Kelly CR, Kunde SS, Khoruts A. Guidance on preparing an investigational new drug application for fecal microbiota transplantation studies. Clinical Gastroenterology and Hepatology 2014;12:283–288. https://doi.org/10.1016/j. cgh.2013.09.060.
• Blackburn LM, Andrea Bales B, Mary Caldwell MS C, Lee Cordell M, Susan Hamilton B, Haley Kreider B. Fecal microbiota transplantation in patients with cancer undergoing treatment. Clin J Oncol Nurs 2015;19 1 :111-4. https://doi. org/10.1188/15.CJON.111-114
• Yoldaş G. Türeyen A. Fekal Mikrobiyota Transplantasyonu Ve Hemşirelik. Anadolu Hemşirelik ve Sağlık Bilimleri Dergisi 2020;23 4 :534-539. https:// doi.org/10.17049/ataunihem.490181
• Leis S, Borody TJ, Jiang C, Campbell J. Fecal microbiota transplantation: A ‘How-To’ guide for nurses. Collegian 2015;22 4 :445-451. https://doi. org/10.1016/J.COLEGN.2014.08.002
• Aas J, Gessert CE, Bakken JS. Recurrent Clostridium difficile colitis: Case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clinical Infectious Diseases 2003;36:580-585. https://doi. org/10.1086/367657
• Brandt LJ, Aroniadis OC, Mellow M, Kanatzar A, Kelly C, Park T. Long- TermFollow-Up of Colonoscopic Fecal Microbiota Transplantfor Recurrent Clostridium difficile Infection. Am J Gastroenterol 2012;107 7 :1079-87. https://doi.org/10.1038/aj.2012.60
• Mattila E, Uusitalo–Seppälä R, Wuorela M, Lehtola L, Nurmi H, Ristikankare M, et al. Fecal Transplantation, Through Colonoscopy, Is Effective Therapy for Recurrent Clostridium difficile Infection. Gastroenterology 2012;142 3 :490- 6. https://doi.org/10.1053/j.gastro.2011.11.037
• Lynch SM, Mu J, Grady JJ, Stevens RG, Devers TJ. Fecal Microbiota Transplantation for Clostridium difficile Infection: A One-Center Experience. Dig Dis 2019;37 6 :467-72. https://doi.org/10.1159/000499873